Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Sarda

Showing results (121-130 of 150) with videos related to

Pageof 15
Sort By:
Journal of Immunological Methods|January 4, 2005
Evaluation of immunoassays for the measurement of soluble transferrin receptor as an indirect biomarker of recombinant human erythropoietin misuse in sportR Abellan, R Ventura, S Pichini, et al.
Journal of Molecular and Cellular Cardiology|May 1, 1997
Lack of evidence for connexin 43 gene mutations in human autosomal recessive lateralization defectsS Debrus, S Tuffery, R Matsuoka, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|January 21, 2012
Clinical outcomes, quality of life, and costs associated with implantation of vagus nerve stimulation therapy in pediatric patients with drug-resistant epilepsySandra L Helmers, Mei Sheng Duh, Annie Guérin, et al.
Clinical Ophthalmology (Auckland, N.Z.)|August 28, 2024
The MOSAIC Study: A Mixed-Methods Study of the Clinical, Emotional, and Financial Burden of Geographic Atrophy Among Patients and Caregivers in the USSophie J Bakri, Winfried M K Amoaku, Danielle Altman, et al.
Epilepsy & Behavior : E&B|August 30, 2011
Clinical and economic impact of vagus nerve stimulation therapy in patients with drug-resistant epilepsySandra L Helmers, Mei Sheng Duh, Annie Guérin, et al.
Pediatric Pulmonology|March 17, 2021
Development of a severity scale to assess chronic lung disease after extremely preterm birthHugh M O'Brodovich, Robin Steinhorn, Robert M Ward, et al.
British Journal of Haematology|September 21, 2001
Prevalence of HFE mutations in people from North Africa living in southern FranceP Aguilar-Martinez, M C Picot, F Becker, et al.
Current Medical Research and Opinion|August 27, 2021
Comparative effectiveness of pegcetacoplan versus ravulizumab in patients with paroxysmal nocturnal hemoglobinuria previously treated with eculizumab: a matching-adjusted indirect comparisonRachel H Bhak, Nikita Mody-Patel, Scott B Baver, et al.
Clinical Therapeutics|March 11, 2018
Corrigendum to 'Effects of Delayed-release Dimethyl Fumarate (DMF) on Health-related Quality of Life in Patients With Relapsing-remitting Multiple Sclerosis: An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies: [Clinical Therapeutics 36 (2014) 1958-1971]Mariko Kita, Robert J Fox, Ralf Gold, et al.
Clinical Therapeutics|October 16, 2014
Effects of delayed-release dimethyl fumarate (DMF) on health-related quality of life in patients with relapsing-remitting multiple sclerosis: an integrated analysis of the phase 3 DEFINE and CONFIRM studiesMariko Kita, Robert J Fox, Ralf Gold, et al.
Pageof 15

Showing results (121-130 of 150) with videos related to

Sort By:
Pageof 15
Journal of Immunological Methods|January 4, 2005
Evaluation of immunoassays for the measurement of soluble transferrin receptor as an indirect biomarker of recombinant human erythropoietin misuse in sportR Abellan, R Ventura, S Pichini, et al.
Journal of Molecular and Cellular Cardiology|May 1, 1997
Lack of evidence for connexin 43 gene mutations in human autosomal recessive lateralization defectsS Debrus, S Tuffery, R Matsuoka, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|January 21, 2012
Clinical outcomes, quality of life, and costs associated with implantation of vagus nerve stimulation therapy in pediatric patients with drug-resistant epilepsySandra L Helmers, Mei Sheng Duh, Annie Guérin, et al.
Clinical Ophthalmology (Auckland, N.Z.)|August 28, 2024
The MOSAIC Study: A Mixed-Methods Study of the Clinical, Emotional, and Financial Burden of Geographic Atrophy Among Patients and Caregivers in the USSophie J Bakri, Winfried M K Amoaku, Danielle Altman, et al.
Epilepsy & Behavior : E&B|August 30, 2011
Clinical and economic impact of vagus nerve stimulation therapy in patients with drug-resistant epilepsySandra L Helmers, Mei Sheng Duh, Annie Guérin, et al.
Pediatric Pulmonology|March 17, 2021
Development of a severity scale to assess chronic lung disease after extremely preterm birthHugh M O'Brodovich, Robin Steinhorn, Robert M Ward, et al.
British Journal of Haematology|September 21, 2001
Prevalence of HFE mutations in people from North Africa living in southern FranceP Aguilar-Martinez, M C Picot, F Becker, et al.
Current Medical Research and Opinion|August 27, 2021
Comparative effectiveness of pegcetacoplan versus ravulizumab in patients with paroxysmal nocturnal hemoglobinuria previously treated with eculizumab: a matching-adjusted indirect comparisonRachel H Bhak, Nikita Mody-Patel, Scott B Baver, et al.
Clinical Therapeutics|March 11, 2018
Corrigendum to 'Effects of Delayed-release Dimethyl Fumarate (DMF) on Health-related Quality of Life in Patients With Relapsing-remitting Multiple Sclerosis: An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies: [Clinical Therapeutics 36 (2014) 1958-1971]Mariko Kita, Robert J Fox, Ralf Gold, et al.
Clinical Therapeutics|October 16, 2014
Effects of delayed-release dimethyl fumarate (DMF) on health-related quality of life in patients with relapsing-remitting multiple sclerosis: an integrated analysis of the phase 3 DEFINE and CONFIRM studiesMariko Kita, Robert J Fox, Ralf Gold, et al.
Pageof 15